IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $369,619 | +997.1% | 9,628 | +442.1% | 0.01% | +1100.0% |
| Q2 2023 | $33,691 | +10363.0% | 1,776 | -91.5% | 0.00% | -90.0% |
| Q1 2023 | $322 | +455.2% | 20,801 | +540.6% | 0.01% | +400.0% |
| Q4 2022 | $58 | -99.9% | 3,247 | -72.2% | 0.00% | +100.0% |
| Q3 2022 | $65,000 | +195.5% | 11,683 | +102.8% | 0.00% | – |
| Q2 2022 | $22,000 | -61.4% | 5,760 | -44.8% | 0.00% | -100.0% |
| Q1 2022 | $57,000 | -14.9% | 10,430 | +31.4% | 0.00% | 0.0% |
| Q4 2021 | $67,000 | -24.7% | 7,938 | -22.8% | 0.00% | -50.0% |
| Q3 2021 | $89,000 | +107.0% | 10,287 | +151.7% | 0.00% | +100.0% |
| Q2 2021 | $43,000 | -53.3% | 4,087 | -28.9% | 0.00% | -50.0% |
| Q1 2021 | $92,000 | -18.6% | 5,746 | +134.5% | 0.00% | -33.3% |
| Q4 2020 | $113,000 | -18.7% | 2,450 | -37.9% | 0.00% | +50.0% |
| Q3 2020 | $139,000 | +434.6% | 3,946 | +274.0% | 0.00% | +100.0% |
| Q2 2020 | $26,000 | – | 1,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |